Patients and prescribers may still see intermittent and limited localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies, the FDA said on Friday
Safety, Tolerability, and Who Benefits Most From Personalized Dosing Adjustment Higher semaglutide doses are not universally better
The normalization of GLP-1 microdosing is a slippery slope that once again targets women, promotes thinness even at the cost of our health, and sets us up for failure in the long-term
10.1111/jocd.12245 29 D'OrazioJ.JarrettS.Amaro-OrtizA.ScottT
Despite extensive animal data suggesting efficacy across depression, anxiety, cognitive decline, and ADHD-relevant models, not a single human clinical trial exists for any mental health application
#drugdiscovery #drugdevelopment #drugdiscoveryanddevelopment #diabetes #obesity #dcgi #prediabetic #disease Pharma Press Global Controller, Food & Drugs Administration, Madhya Pradesh #injectable #diabetestreatment To view or add a comment, sign in Big news for diabetes and obesity management in India